Skip to main content

Table 2 Characteristics of lesions

From: 90Y-PET/CT-based dosimetry after selective internal radiation therapy predicts outcome in patients with liver metastases from colorectal cancer

  Min Q1 Median Q3 Max
Baseline TLG (g) 10 36 71 165 1228
Baseline SUVpeak (g/ml) 3 5 6 8 13
Follow-up TLG (g) 0 0 7 61 5115
Follow-up SUVpeak (g/ml) 1 3 4 5 14
TLG-decrease (%) − 1116 8 96 100 100
SUVpeak-decrease (%) − 45 11 43 57 91
Lesion mean absorbed dose (Gy) 8 39 55 89 268